Terms: = Testicular cancer AND CEACAM5, CEA AND Staging
5 results:
1. Ovarian Sertoli-Leydig Cell Tumors: Epidemiological, Clinical and Prognostic Factors.
Castro BGR; Souza CP; Andrade CEMDC; Vieira MA; Andrade DAP; Reis RD
Rev Bras Ginecol Obstet; 2019 Jul; 41(7):440-448. PubMed ID: 31344718
[TBL] [Abstract] [Full Text] [Related]
2. Mucinous adenocarcinoma as heterologous element in intermediately differentiated Sertoli-Leydig cell tumor of the ovary.
Virk R; Lu D
Pathol Res Pract; 2010 Jul; 206(7):489-92. PubMed ID: 19674851
[TBL] [Abstract] [Full Text] [Related]
3. Clinical usefulness of serum ferritin measurements in patients with testicular germ cell tumors.
Szymendera JJ; Kozłowicz-Gudzinska I; Madej G; Sikorowa L; Kaminska JA; Kowalska M
Oncology; 1985; 42(4):253-8. PubMed ID: 2409496
[TBL] [Abstract] [Full Text] [Related]
4. Overview of oncofetal antigens in cancer.
Wepsic HT
Ann Clin Lab Sci; 1983; 13(4):261-6. PubMed ID: 6194734
[TBL] [Abstract] [Full Text] [Related]
5. Value of five tumor markers (AFP, cea, hCG, hPL and SP1) in diagnosis and staging of testicular germ cell tumors.
Szymendera JJ; Zborzil J; Sikorowa L; Kamińska JA; Gadek A
Oncology; 1981; 38(4):222-9. PubMed ID: 6165945
[TBL] [Abstract] [Full Text] [Related]
